Anavex Life Sciences
AVXL
AVXL
59 hedge funds and large institutions have $29.7M invested in Anavex Life Sciences in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
11% more funds holding
Funds holding: 53 → 59 (+6)
92% less call options, than puts
Call options by funds: $491K | Put options by funds: $6.04M
Holders
59
Holding in Top 10
1
Calls
$491K
Puts
$6.04M
Top Buyers
| 1 | +$5.94M | |
| 2 | +$2.87M | |
| 3 | +$821K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$680K |
| 5 |
Morgan Stanley
New York
|
+$495K |
Top Sellers
| 1 | -$434K | |
| 2 | -$144K | |
| 3 | -$75K | |
| 4 |
Millennium Management
New York
|
-$73K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$67K |